Business Description
Mycenax Biotech Inc
NAICS : 325412
SIC : 2834
ISIN : TW0004726005
Description
Mycenax Biotech Inc is a Taiwan-based biopharmaceutical company. It is engaged in the development and manufacture of biopharmaceutical products, specializing in mammalian and microbial cell-derived biologics. The company provides services for program evaluation/confirmation, cell line development, and construction, process development technology platforms, drug characterization analysis, the establishment of testing methods, and drug production in accordance with PIC/S GMP manufacturing standards.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.44 | |||||
| Equity-to-Asset | 0.6 | |||||
| Debt-to-Equity | 0.44 | |||||
| Debt-to-EBITDA | -4.79 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 3.57 | |||||
| Beneish M-Score | -3.38 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -15 | |||||
| 3-Year FCF Growth Rate | -45 | |||||
| 3-Year Book Growth Rate | 8 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.51 | |||||
| 9-Day RSI | 48.35 | |||||
| 14-Day RSI | 46.1 | |||||
| 6-1 Month Momentum % | -27.25 | |||||
| 12-1 Month Momentum % | 27.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.29 | |||||
| Quick Ratio | 1.17 | |||||
| Cash Ratio | 0.63 | |||||
| Days Inventory | 40.58 | |||||
| Days Sales Outstanding | 34.93 | |||||
| Days Payable | 18.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -17.1 | |||||
| Shareholder Yield % | 0.06 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -42.09 | |||||
| Operating Margin % | -73.48 | |||||
| Net Margin % | -79.71 | |||||
| FCF Margin % | -81.16 | |||||
| ROE % | -22.94 | |||||
| ROA % | -14.77 | |||||
| ROIC % | -16.67 | |||||
| ROC (Joel Greenblatt) % | -21.62 | |||||
| ROCE % | -16.68 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 13.28 | |||||
| PB Ratio | 4.27 | |||||
| Price-to-Tangible-Book | 4.35 | |||||
| EV-to-EBIT | -19 | |||||
| EV-to-EBITDA | -49.49 | |||||
| EV-to-Revenue | 14.09 | |||||
| EV-to-FCF | -17.53 | |||||
| Price-to-Median-PS-Value | 1.25 | |||||
| Earnings Yield (Greenblatt) % | -5.26 | |||||
| FCF Yield % | -6.12 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mycenax Biotech Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 672.85 | ||
| EPS (TTM) (NT$) | -2.6 | ||
| Beta | 0.84 | ||
| Volatility % | 38.33 | ||
| 14-Day RSI | 46.1 | ||
| 14-Day ATR (NT$) | 1.515555 | ||
| 20-Day SMA (NT$) | 43.625 | ||
| 12-1 Month Momentum % | 27.82 | ||
| 52-Week Range (NT$) | 34.9 - 65.2 | ||
| Shares Outstanding (Mil) | 207.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mycenax Biotech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mycenax Biotech Inc Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Mycenax Biotech Inc Frequently Asked Questions
What is Mycenax Biotech Inc(ROCO:4726)'s stock price today?
The current price of ROCO:4726 is NT$43.30. The 52 week high of ROCO:4726 is NT$65.20 and 52 week low is NT$34.90.
When is next earnings date of Mycenax Biotech Inc(ROCO:4726)?
The next earnings date of Mycenax Biotech Inc(ROCO:4726) is .
Does Mycenax Biotech Inc(ROCO:4726) pay dividends? If so, how much?
Mycenax Biotech Inc(ROCO:4726) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers